Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia
Lizane S Cruz1, Caroline M Kopruszinski, Juliana G Chichorro
1Department of Pharmacology, Federal University of Parana, Curitiba, Parana, Brazil.
Abstract:
Trigeminal ganglion C-fiber neurons bearing transient receptor potential vanilloid-1 (TRPV1) channels are selectively destroyed by resiniferatoxin (RTX), a potent capsaicin analogue. The current study assessed the effect of an RTX injection (200 ng/4 μl) into the trigeminal ganglion in inflammatory and neuropathic rat models of orofacial thermal hyperalgesia. Intraganglionar RTX injection resulted in trigeminal ganglion C-fiber deletion, which was confirmed by the capsaicin eye wipes test, performed 6 days after the injection. The nociceptive responses induced by 2.5% formalin injected into the orofacial region were unchanged by a previous intraganglionar RTX injection. However, orofacial heat and cold hyperalgesia, induced by carrageenan injected into the upper lip (50 µg/50 μl), was abolished by previous intraganglionar RTX treatment. In addition, the development of orofacial heat and cold hyperalgesia after constriction of the infraorbital nerve was prevented by previous RTX treatment. Thus, trigeminal ganglion neurons expressing TRPV1 are crucial for the development of orofacial inflammatory and neuropathic thermal hyperalgesia.
Insights
Resiniferatoxin (RTX) selectively destroys trigeminal ganglion C-fiber neurons expressing TRPV1 channels. This treatment abolished orofacial inflammatory and neuropathic thermal hyperalgesia in rats, highlighting TRPV1
Area of Science:
- Neuroscience
- Pain Research
- Pharmacology
Background:
- Trigeminal ganglion C-fibers expressing Transient Receptor Potential Vanilloid-1 (TRPV1) channels are implicated in orofacial pain signaling.
- Resiniferatoxin (RTX), a capsaicin analog, selectively ablates TRPV1-expressing neurons.
Purpose of the Study:
- To investigate the role of RTX-sensitive trigeminal ganglion C-fibers in orofacial inflammatory and neuropathic thermal hyperalgesia.
Main Methods:
- Intraganglionic injection of RTX into the trigeminal ganglion of rats.
- Assessment of C-fiber deletion using the capsaicin eye wipe test.
- Induction of orofacial hyperalgesia using carrageenan (inflammatory) or infraorbital nerve constriction (neuropathic models).
- Evaluation of nociceptive responses to formalin injection.
Main Results:
- RTX injection successfully depleted trigeminal ganglion C-fibers.
- RTX treatment did not alter formalin-induced nociception.
- RTX administration abolished carrageenan-induced orofacial thermal hyperalgesia.
- RTX treatment prevented the development of orofacial thermal hyperalgesia following infraorbital nerve constriction.
Conclusions:
- Trigeminal ganglion neurons expressing TRPV1 are essential for the development of orofacial inflammatory and neuropathic thermal hyperalgesia.
- Targeting TRPV1-expressing C-fibers with RTX offers a potential therapeutic strategy for managing orofacial pain conditions.
Related Concept Videos
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Analgesia and Pain Management
Nociception
Ligand-Gated Ion Channel Receptor: Gating Mechanism


